Immucell (ICCC) Short term Debt (2010 - 2026)

Immucell (ICCC) has reported Short term Debt for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt fell 1.9% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $1.5 million (down 1.9% YoY), and the FY2025 full-year result was $1.6 million, up 7.52% from the prior year.
• Short term Debt slipped to $1.5 million in Q2 2026 per ICCC's latest filing, from $1.6 million in the prior quarter.
• Across five years, Short term Debt topped out at $1.6 million in Q4 2025 and bottomed at $947279.0 in Q1 2022.
• Historically, Short term Debt has averaged $1.3 million across 5 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Short term Debt jumped 41.38% in 2023, then retreated 1.9% in 2026.
• Over 5 years, Short term Debt stood at $1.0 million in 2022, then jumped by 37.46% to $1.4 million in 2023, then advanced by 4.82% to $1.5 million in 2024, then increased by 7.52% to $1.6 million in 2025, then slipped by 6.46% to $1.5 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $1.5 million, $1.6 million, and $1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.